PPT-Drug Interactions Update in the Transplant Patient

Jennifer N Fosnot PharmD Nurse Practitioners Symposium Nashville TN September 2728 th 2012 Objectives 1 Discuss the CYP 450 enzymes and common drug interactions with the immunosuppressants. HERB-DRUG INTERACTIONS AND PATIENT COUNSELING MOHAMMAD YAHEYA MOHAMMAD ISMAIL* Dept. of Pharmacy, Higher College of Technology, P.O.Box 74 PC 133, Sultanate of Oman E mail: mohammadyaheya@yahoo.com ( Duri. . Xixi. Hong. . Joseph . Lustig. Aleksandra . Porebska. . C-. Src. Kinase Inhibition: . A Promising Route in Kidney Cancer Treatment. Outline. Overview of c-. Src. Activation/VEGF pathway. . . Dr Siobhan MacHale. Consultant Liaison . Psychiatrist. TUN conference Nov 27. th. 2015. . Outline. Adjustment. Adaptive . - maladaptive . adjustment. Concordance. Louis Wu, PA-C. Presented at VAPAA Annual Meeting. . March 2, 2017. . Financial Disclosures and Conflicts. I have no financial disclosures nor conflicts concerning this talk. . . Learning Objectives. Dr Shaheen. Delivered By . Dr Naser . Drug interactions- objectives. Discuss Pharmacokinetic interactions. List . Pharmacodynamic. interactions. Comment . on common Drug- Food interactions. Drug interactions. Lisa Donovan, . Transplant Financial Coordinator, . SUNY Upstate university hospital, Syracuse, NY. Deidra . Simano. , . Transplant operations analyst, Dartmouth-Hitchcock medical center, . lebanon. , . . Department . of Pharmaceutics. 1. 26-Feb-16. Drug interactions . :. . These are said . to occur when the pharmacological activity of a drug is altered by the concomitant use of another drug or by the presence of some other substance. . Drug-Drug Interactions. Basic mechanisms of drug-drug interactions. Clinical significance of drug-drug interactions. Minimizing adverse drug-drug interactions. Drug-Drug Interactions. Interactions can occur whenever a patient takes more than one drug.. Friday, October 5, 2012. Transplant . Center Growth and. Management Best Practices. 1. . Institutional Vision and Commitment. 2. Dedicated Team. 3. Aggressive Clinical Style. 4. . Patient and “Family” Centered Care. An Antiretroviral Therapy Review. Sarah Pérez, PharmD, PhC, BCACP, AAHIVP. Disclosure. The speaker has no actual or potential conflicts of interest in relation to this presentation. . Objectives. Pharmacists. – what do I need to know?”. Clinical considerations for patients who have received heart transplant or mechanical circulatory support device. Jennifer Gatten, FNP-C, CCTC. Diane Holmes, MSN, FNP-BC, CHFN, CCTC. Content. : Eljim Tesoro, PharmD, BCCCP, FNCS, FCCM;. Mehrnaz Pajoumand, PharmD . Slides. : Eljim Tesoro, PharmD, BCCCP, FNCS, FCCM .  .  .  .  . Editors’ Note: Global Considerations. The intent of the editors, authors, and reviewers of this ENLS topic was not to address all the variations in international practice for the different diseases. We have discussed major practice variances (e.g., the availability of diagnostic testing, or the type of medications used) and encourage learners to use the ENLS algorithms as a framework on which any relevant local practice guidelines can be incorporated.. Drug Drug Interaction Extraction from Product Labels . Bharath . Dandala. (. bdand@us.ibm.com. ). Diwakar Mahajan (. dmahaja@us.ibm.com. ). Ananya Poddar (. poddar@us.ibm.com. ). Introduction. Drug to drug interactions is the most common cause of adverse events, and preventable adverse events are the eighth leading cause of death in the United States.. (Some practice with interactions). 1. Interactions occur when effects of one factor . differ among levels of another factor.. Illustrate with hypothetical results: test of . a Drug’s effect in females vs. males..